Clonorchis sinensis, an oriental liver fluke, as a human biological agent of cholangiocarcinoma: a brief review

  • Kim, Tong-Soo ;
  • Pak, Jhang Ho ;
  • Kim, Jong-Bo ;
  • Bahk, Young Yil
  • Received : 2016.07.04
  • Published : 2016.11.30


Parasitic diseases remain an unarguable public health problem worldwide. Liver fluke Clonorchis sinensis is a high risk pathogenic parasitic helminth which is endemic predominantly in Asian countries, including Korea, China, Taiwan, Vietnam, and the far eastern parts of Russia, and is still actively transmitted. According to the earlier $8^{th}$ National Survey on the Prevalence of Intestinal Parasitic Infections in 2012, C. sinensis was revealed as the parasite with highest prevalence of 1.86% in general population among all parasite species surveyed in Korea. This fluke is now classified under one of the definite Group 1 human biological agents (carcinogens) by International Agency of Research on Cancer (IARC) along with two other parasites, Opisthorchis viverrini and Schistosoma haematobium. C. sinensis infestation is mainly linked to liver and biliary disorders, especially cholangiocarcinoma (CCA). For the purposes of this mini-review, we will only focus on C. sinensis and review pathogenesis and carcinogenesis of clonorchiasis, disease condition by C. sinensis infestation, and association between C. sinensis infestation and CCA. In this presentation, we briefly consider the current scientific status for progression of CCA by heavy C. sinensis infestation from the food-borne trematode and development of CCA.


Cholangiocarcinoma;Clonorchiasis;Clonorchis sinensis;Liver cancer;Liver flukes


  1. Oh J-K and Weiderpass E (2014) Infection and cancer: Global distribution and burden of diseases. Ann Glob Health 80, 384-392
  2. Choi D, Lim JH, Lee KT et al (2006) Cholangiocarcinoma and Clonorchis sinensis infection: A care-control study in Korea. J Hepatol 44, 1066-1073
  3. Lim MK, Ju YH, Franceschi S et al (2006) Clonorchis sinensis infection and increasing risk of cholangiocarcinoma in the Republic of Korea. Am J Trop Med Hyg 75, 93-96
  4. Honjo S, Srivatanakul P, Sriplung H et al (2005) Genetic and environmental determinants of risk for cholangiocar-cinoma via Opisthorchis viverrini in a densely infested area in Nakhon Phanom, northeast Thailand. Int J Cancer 117, 854-860
  5. International Agency for Research on Cancer (2011) Monographs on the evaluation of carcinogenic risks to humans. A review of carcinogen - Part B: Biological Agents. Lyon, France
  6. Shin H-R, Oh J-K, Lim MK et al (2010) Descriptive epidemiology of cholangiocarcinoma and clonorchiasis in Korea. J Korean Med Sci 25, 1011-1016
  7. Viranuvatti V, Kshemsant D and Bhamarapravati N (1955) Retention cyst of liver caused by opisthorchiasis associated with carcinoma; Case report. Am J Gastroenterol 23, 442-446
  8. Hou PC (1956) Relationship between primary carcinoma of the liver and infestation with Clonorchis sinensis. J Pathol Bacteriol 72, 239-246
  9. Huang S-Y, Zhao G-H, Fu B-Q et al (2012) Genomics and molecular genetics of Clonorchis sinensis: Current status and perspectives. Parasitol Int 61, 71-76
  10. Vennervald BJ and Polman K (2009) Helminths and malignancy. Parasite Immunol 31, 686-696
  11. Lim MK, Ju Y-H, Franceschi S et al (2006) Clonorchis sinensis infection and increasing risk of cholangiocarcinoma in the Republic of Korea. Am J Trop Med Hyg 75, 93-96
  12. Sripa B, Brindley PJ, Mulvenna J et al (2012) The tumorigenic liver fluke Opisthorchis viverrini - Multiple pathways to cancer. Trends Parasitol 28, 395-407
  13. Chai JY, Murrell KD and Lymbery AJ (2005) Fish-borne parasitic zoonoses: Status and issues. Inter J Parasitol 35, 1233-1254
  14. Sripa B, Kaewkes S, Sithithaworn P et al (2007) Liver fluke induces cholangiocarcinoma. PLoS Med 4, e201
  15. Rim HJ, Lyu KS, Lee JS et al (1981) Clinical evaluation of the therapeutic efficacy of paraziquantel (Embay 8440) against Clonorchis sinensis infection in man. Ann Trop Med Parasitol 75, 27-33
  16. Ambroise-Thomas P and Goullier A (1984) Parasitological examinations and immunodiagnostic advances in fluke infection. Arzneimittelforschung 34, 1129-1132
  17. Kang J-M, Ju H-L, Lee J et al (2015) Mapping the putative epitope domain of Clonorchis sinensis paramyosin (CsPmy) recognized by CsPmy-specific immunoglobulin G in sera of human clonorchiasis. Mol Biochem Parasitol 201, 66-71
  18. Kim TI, Na BK and Hong SJ (2009) Functional genes and proteins of Clonorchis sinensis. Korean J Parasitol 47 (Suppl), S59-68
  19. Park GM (2007) Genetic comparison of liver flukes, Clonorchis sinensis and Opisthorchis viverrini based on rDNA and mtDNA gene sequences. Parasitol Res 100, 351-357
  20. Lim JH (1990) Radiologic findings of clonorchiasis. Am J Roentgenol 155, 1001-1008
  21. Xiao SH, Hui-Ming W, Tanner M et al (2005). Tribendi-midine: A promising, safe and broad-spectrum anthelmintic agent from China. Acta Trop 94, 1-14
  22. Echaubard P, Sripa B, Mallory FF and Wilcox BA (2016) The role of evolutionary biology in research and control of liver flukes in southeast Asia. Infect Genet Evol [Epub ahead of print]
  23. Kim JH, Choi MH, Bae YM et al (2011) Correlation between discharged worms and fecal egg counts in human clonorchiasis. PLoS Negl Trop Dis 5, e1339
  24. Qiao T, Ma RH, Luo XB et al (2012) Cholecystollithiasis is associated with Clonorchis sinensis infection. PLoS One 7, e42471
  25. Korean National Research Institute of Health, Centers for Disease Control & Prevention (2013) Prevalence of intestinal parasitic infections in Korea -The 8th report
  26. Gibson JB and Sobin LH (1978) Histological typing of tumors of the liver biliary tract and pancreas. Geneva, World Health Organization
  27. Blechacz B and Gores GJ (2008) Cholangiocarcinoma: Advances on pathogenesis, diagnosis, and treatment. Hepatol 48, 308-321
  28. Bouvard V, Baan R, Straif K et al (2009) A review of human carcinogens - Part B: Biological agents. Lancet Oncol 10, 321-322
  29. Maeng A, Lee HW, Bashir Q et al (2016) Oxidative stress-mediated mouse liver lesions caused by Clonorchis sinensis infection. Int J Parasitol 46, 195-204
  30. Kawai T and Akira S (2011) Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 34, 637-650
  31. Yan C, Li X-Y, Li B et al (2015) Expression of Toll-like receptor (TLR) 2 and TLR4 in the livers of mice infected by Clonorchis sinensis. J Infect Dev Ctries 9, 1147-1155
  32. Liu Q and Ding JL (2016) The molecular mechanisms of TLR-signaling cooperation in cytokine regulation. Immunol Cell Biol [Epub ahead of print]
  33. Choi YK, Yoon BI, Won YS et al (2003) Cytokine responses in mice infected with Clonorchis sinensis. Parasitol Res 91, 87-93
  34. Kim EM, Bae YM, Choi MH and Hong ST (2012) Cyst formation, increased anti-inflammatory cytokines and expression of chemokines support for Clonorchis sinensis infection in FVB mice. Parasitol Int 61, 124-129
  35. Bhamarapravati N, Thammavit W and Vajrasthira S (1978) Liver changes in hamsters infected with a liver fluke of man, Opisthorchis viverrini. Am J Trop Med Hyg 38, 356-362
  36. Wills-Karp M, Santeliz J and Karp CL (2001) The germless theory of allergic disease: Revisiting the hygiene hypothesis. Nat Rev Immunol 1, 69-75
  37. Okada H, Kuhn C, Feillet H and Bach J-F (2010) The 'hygiene hypothesis' for autoimmune and allergic diseases: An update. Clin Exper Immunol 160, 1-9
  38. Fallon PG and Mangan NE (2007) Suppression of $T_H2$-type allergic reactions by helminth infection. Nat Rev Immunol 7, 220-230
  39. Jeong Y-I, Kim SH, Ju JW et al (2011) Clonorchis sinensis-derived total protein attenuates airway inflammation in murine asthma model by inducing regulatory T cells and modulating dendritic cell functions. Biochem Biophys Res Comm 407, 793-800
  40. Jeong Y-I, Kim YJ, Ju JW et al (2014) Identification of anti-allergic effect of Clonorchis-derived protein venom allergen-like proteins (CsVAL). Biochem Biophys Res Comm 445, 549-555
  41. Dunne DW and Cooke A (2005) A worm's eye view of the immune system: Consequences for evolution of human autoimmune diseases. Nat Rev Immunol 5, 420-426
  42. Nam J-H, Moon JH, Kim IK et al (2012) Free radicals enzymatically triggered by Clonorchis sinensis excretory-secretory products cause NF-${\kappa}B$-mediated inflammation in human cholangiocarcinoma cells. Int J Parasitol 42, 103-113
  43. Esquela-Kerscher A and Slack FJ (2006) Oncomirs - MicroRNAs with a role in cancer. Nat Rev 6, 259-269
  44. Namwat N, Chusorn P, Loilome W et al (2012) Expression profiles of oncomir miR-21 and tumor suppressor let-7a in the progression of opisthorchiasis-associated cholangio-carcinoma. Asian Pac J Cancer Prev 13, 65-69
  45. Ministry of Health and Welfare, Korea Association of Health Promotion (2004) Prevalence of intestinal parasitic infection in Korea -The 7th report
  46. Jeong Y-I, Shin H-E, Lee S-E et al (2016) Prevalence of Clonorchis sinensis infection among residents along 5 major rivers in the Republic of Korea. Korean J Parasitol 54, 215-221
  47. Li T, He S, Zhao G et al (2010) Major trends in human parasitic diseases in China. Trends Parasitol 26, 264-270
  48. Hong ST, Huh S, Kho WG et al (1990) Changes of histopathological and serological findings of the liver after treatment in rabbit clonorchiasis. Seoul J Med 31, 117-127
  49. Min HK (1984) Clonorchis sinensis: Pathogenesis and clinical features of infection. Arzneimittelforschung 34, 1151-1153
  50. Kim YJ, Choi MH, Hong ST et al (2008) Proliferative effects of excretory/secretory products from Clonorchis sinensis on the human epithelial cell line HEK293 via regulation of the transcription factor E2F1. Parasitol Res 102, 411-417
  51. Kim YJ, Choi MH, Hong ST et al (2009) Resistance of cholangiocarcinoma cells to parthenolide-induced apoptosis by the excretory-secretory products of Clonorchis sinensis. Parasitol Res 104, 1011-1016
  52. Yoo WG, Kim D-W, Ju J-W et al (2011) Developmental transcriptomic features of the carcinogenic liver fluke, Clonorchis sinensis. PLoS Neg Trop Dis 5, e1208
  53. Fava G and Lorenzini I (2012) Molecular pathogenesis of cholangiocarcinoma. Int J Hepatol Article 2012, 630543
  54. Kawanishi S and Hiraku Y (2006) Oxidative and nitrative DNA damage as biomarker for carcinogenesis with special reference to inflammation. Antioxid Redox Signal 8, 1047-1058
  55. Choi BI, Han JK, Hong ST and Lee KH (2004) Clonorchiasis and cholangiocarcinoma: Etiologic relationship and imaging diagnosis. Clin Microbiol Rev 17, 540-552
  56. Choi M-H, Park IC, Li S and Hong S-T (2003) Excretory-secretory antigen is better than crude antigen for the serodiagnosis of clonorchiasis by ELISA. Korean J Parasitol 41, 35-38
  57. Pak JH, Kim D-W, Moon JH et al (2009) Differential gene expression profiling in human cholangiocarcinoma cells treated with Clonorchis sinensis excretory-secretory products. Parasitol Res 104, 1011-1016
  58. Kim D-W, Kim J-Y, Moon JH et al (2010) Transcriptional induction of minichromosome maintenance protein 7 (Mcm7) in human cholangiocarcinoma cells treated with Clonorchis sinensis excretory-secretory products. Mol Biochem Parasitol 173, 10-16
  59. Pak JH, Moon JH, Hwang SJ et al (2009) Proteomic analysis of differentially expressed proteins in human cholangiocarcinoma cells treated with Clonorchis sinensis excretory-secretory products. J Cell Biochem 108, 1376-1388
  60. Pak JH, Kim IK, Kim SM et al (2014) Induction of cancer-related microRNA expression profiling using excretory-secretory products of Clonorchis sinensis. Parasitol Res 113, 4447-4455
  61. Ju JW, Joo HN, Lee MR et al (2009) Identification of a serodiagnostic antigen, legumain, by immunoproteomic analysis of excretory-secretory products of Clonorchis sinensis adult worms. Proteomics 9, 3066-3078
  62. Khurana S, Dubey ML and Malla N (2005) Association of parasitic infections and cancers. Indian J Med Microbiol 23, 74-79
  63. Oshima H, Bandaletova TY, Brouet I et al (1994) Increased nitrosamine and nitrate biosynthesis mediated by nitric oxide synthase induced in hamsters infected with liver fluke (Opisthorchis viverrini). Carcinogenesis 15, 271-275
  64. Yang Q-L, Shen J-Q, Xue Y et al (2015) Pathological lesions and inducible nitric oxide synthase expressions in the liver of mice experimentally infected with Clonorchis sinensis. Korean J Parasitol 53, 777-783
  65. Pinlaor S, Ma N, Hiraku Y et al (2004) Repeated infection with Opisthorchis viverrini induces accumulation of 8-nitroguanine and 8-oxo-7,8-dihydro-2'-deoxyguanine in the bile duct of hamsters via inducible nitric oxide synthase. Carcinogenesis 25, 1535-1542
  66. Weitzman SA and Gordon LI (1990) Inflammation and cancer: Role of phagocyte-generated oxidants in carcino-genesis. Blood 76, 655-663
  67. Apte RN and Voronov E (2002) Interleukin-1 - A major pleiotropic cytokine in tumor host interactions. Cancer Biol 12, 277-290
  68. Ishimura N, Bronk SF and Gores GJ (2004) Inducible nitric oxide synthase upregulates cyclooxygenase-2 in mouse cholangiocytes promoting cell growth. Gastrointest Liver Physiol 287, G88-G95
  69. Lowenstein CJ and Padalko E (2004) iNOS (NOS2) at a glance. J Cell Sci 117, 2865-2867
  70. Bartsch H and Nair J (2006) Chronic inflammation and oxidative stress in the genesis and perpetuation of cancer: Role of lipid peroxidation, DNA damage and Repair. Langenbeck's Arch Surg 391, 499-510
  71. Reuter S, Gupta SC, Chaturveri MM and Aggarwal BB (2010) Oxidative stress, inflammation and cancer: How are they linked? Free Radical Biol Med 49, 1603-1616
  72. Fitzpatrick FA (2001) Inflammation, carcinogenesis and cancer. Int Immunopharmacol 1, 1651-1667
  73. Furstenberger G, Krieg P, Muller-Decker K and Habenicht AJR (2006) What are cyclooxygenases and lipoxygenases doing in the driver's seat of carcinogenesis? Int J Cancer 119, 2247-2254
  74. Braconi C, Huang N and Patel T (2010) MicroRNA-dependent regulation of DNA methyltransferase-1 and tumor suppressor gene expression by interleukin-6 in human malignant cholangiocyte. Hepathol 51, 881-890
  75. Oshima H and Bartsch H (1994) Chronic infectious and inflammation processes as cancer risk factors: Possible role of nitric oxide in carcinogenesis. Mutat Res 305, 253-264
  76. Brown JR and DuBois RN (2005) COX-2: A molecular target for colorectal cancer prevention. J Clin Oncol 23, 2840-2855
  77. Kim EM, Kim JS, Choi MH et al (2008) Effects of excretory/secretory products from Clonorchis sinensis and the carcinogen dimethylnitrosamine on the proliferation and cell cycle modulation of human epithelial HEK293T cells. Korean J Parasitol 46, 127-132
  78. Uddin MH, Choi MH, Kim WH et al (2015) Involvement of PSMD10, CDK4 and tumor suppressors in development of intrahepatic cholangiocarcinoma of Syrian golden hamsters induced by Clonorchis sinensis and N-nitrosodimethylamine. PLoS Negl Trop Dis 9, e0004008
  79. Hong S-T and Fang Y (2012) Clonorchis sinensis and clonorchiasis, an update. Parasitol Int 61, 17-24
  80. Qian M-B, Utzinger J, Keiser J and Zhou X-N (2016) Clonorchiasis. Lancet 387, 800-810

Cited by

  1. Human liver flukes vol.2, pp.9, 2017,
  2. Oncogenic spiral by infectious pathogens: Cooperation of multiple factors in cancer development vol.109, pp.1, 2017,
  3. Bacillus subtilis spore with surface display of paramyosin from Clonorchis sinensis potentializes a promising oral vaccine candidate vol.11, pp.1, 2018,
  4. Prevention and Control Strategies for Parasitic Infections in the Korea Centers for Disease Control and Prevention vol.56, pp.5, 2018,


Supported by : National Research Foundation of Korea (NRF)